SCHEMBL5658575

SCHEMBL5658575

Cc1cc(C2(c3cc(C)c(O)c(C)c3)C(=O)N(CCc3scnc3C)c3ccccc32)cc(C)c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.42
GPR55 Q9Y2T6 1/20 0.42
CNR2 P34972 1/20 0.38
MAPT P10636 4/20 0.38
MAPK1 P28482 3/20 0.38
HTT P42858 2/20 0.38
TSHR P16473 1/20 0.38
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36
HTR2A P28223 1/20 0.36
ALDH1A1 P00352 6/20 0.34
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
ALOX15 P16050 2/20 0.34
HSD17B10 Q99714 2/20 0.34
USP2 O75604 2/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
SCN9A Q15858 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5660576 0.84 MAPT (0.35) CNR1GPR55CNR2MAPTMAPK1
SCHEMBL5659676 0.81 CNR1 (0.45) CNR1GPR55MAPTTSHRALDH1A1
SCHEMBL5659465 0.79 CNR1 (0.55) CNR1GPR55ALDH1A1MEN1KMT2A
SCHEMBL5658731 0.74 CNR1 (0.52) CNR1GPR55MAPTMAPK1TSHR
SCHEMBL5660564 0.73 TSHR (0.45) CNR1GPR55MAPK1HTTTSHR
SCHEMBL5658821 0.73 CNR1 (0.46) CNR1GPR55MAPTALDH1A1MEN1
SCHEMBL5661069 0.73 CNR1 (0.50) CNR1GPR55MAPTTSHRALDH1A1
SCHEMBL5659203 0.72 CNR1 (0.52) CNR1GPR55MAPTMAPK1ALDH1A1
SCHEMBL14457581 0.70 SCN9A (0.51) CNR1GPR55MAPTALDH1A1SMN1; SMN2
SCHEMBL5659726 0.70 TP53 (0.52) CNR1GPR55MAPTHTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 CNR1 362/4885GPR55 77/4885CNR2 414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.